glycine propionyl l carnitine gplc propionyl-L-carnitine Glycine Propionyl-L-Carnitine HCI GPLC

The integrated service model also ensures better communication, faster problem resolution, and more efficient production scheduling that supports brand growth and market expansion goals

Adenovirus-based therapies Gendicine, the first p53 gene therapy, is a recombinant human p53 adenovirus that was approved in 2003 by the China Food and Drug Administration (CFDA) for the treatment of HNSCC

These results demonstrate that CEs lead to the production of potent ROS, capable of causing DNA damage, thus playing important role not only in carcinogenesis [36] but also in systemic lupus erythematosus (SLE) [40, 37, 39] and RA [38]

This results in the deposition of bilirubin pigments in the tissues and ultimately causes jaundice